Jaw Ching
- SEC CIK
- 0001710875
No open-market purchases or sales filed in the past year.
Current role at each company
- CYTK Cytokinetics IncSVP Finance & CFOas of Mar 7, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Jaw Ching as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 7, 2023 (view filing) | Feb 3 | 4 days | Jaw ChingSVP Finance & CFO | SSale | −15.0K | $45.00 | −$675.0K | −18.3%67.2K after | |
| Apr 6, 2022 (view filing) | Apr 4-5 | 2 days | Jaw ChingSVP Finance & CFO | SSale | −25.0K | $40.80 | −$1.02M | −27.1%67.1K after | 2 lots |
| Mar 9, 2022 (view filing) | Mar 9 | Same day | Jaw ChingSVP Finance & CFO | SSale | −15.0K | $38.00 | −$570.0K | −18.3%67.1K after | |
| Oct 21, 2021 (view filing) | Oct 19 | 2 days | Jaw ChingSVP Finance & CFO | SSale | −35.7K | $35.73 | −$1.28M | −40.2%53.1K after |